According to a new report North America Life Science Analytics Market, published by KBV research, the North America Life Science Analytics Market would witness market growth of 6.7% CAGR during the forecast period (2020-2026).
The US market dominated the North America Software Market by Country 2019, and would continue to be a dominant market till 2026. The Canada market is experiencing a CAGR of 10.6% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 9.6% during (2020 - 2026).
The Sales & Marketing Support market dominated the Canada Life Science Analytics Market by Application 2019, growing at a CAGR of 7.8 % during the forecast period. The Research and Development (R&D) market is exhibiting a CAGR of 8.5% during (2020 - 2026). Additionally, The Pharmacovigilance market is expected to witness highest CAGR of 9.7% during (2020 - 2026).
The Pharmaceutical market dominated the Mexico Life Science Analytics Market by End User 2019, thereby, achieving a market value of $182.9 million by 2026. The Medical Devices market is estimated to grow at a CAGR of 7.8% during (2020 - 2026). Additionally, The Other End Users market is expected to witness highest CAGR of 11.5% during (2020 - 2026).
Report Structural Insights: https://www.kbvresearch.com/north-america-life-science-analytics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Oracle Corporation, IBM Corporation, Microsoft Corporation, Accenture PLC, Cognizant Technology Solutions Corporation, Infosys Limited, IQVIA Holdings, Inc., AllScripts Healthcare Solutions, Inc., Cerner Corporation and SAS Institute, Inc.
By Component
By Application
By End User
By Delivery Mode
By Type
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
